High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer.
Increased copy numbers of 17q23 chromosomal region have been shown to occur in different tumour types and to be associated with tumour progression and with poor prognosis. Several genes have earlier been proposed as potential oncogenes at this region largely on the grounds of cell lines studies. In this study, we performed a systematic gene expression survey on 26 primary breast tumours with known 17q23 amplification status by quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR). The 17q23 amplicon is restricted to an approximately 5 MB region in breast cancer and contains 29 known genes. Our survey revealed a statistically significant (P<0.01) difference between the high level and no amplification groups in a set of eleven genes whereas no difference between the moderate and the non-amplified tumour groups were observed. Interestingly, these 11 genes were located adjacent to one another within a 1.56 Mb core region in which all except one of the genes were overexpressed. These data suggest that only high-level amplification at the 17q23 amplicon core leads to elevated gene expression in breast cancer. Moreover, our results highlight the fact that 17q23 amplicon carries multiple candidate genes and that this may be a more common event in gene amplification than previously thought.
Pärssinen
J
J
Laboratory of Cancer Genetics, Institute of Medical Technology, Tampere University Hospital, University of Tampere, FIN-33014, Finland.
Kuukasjärvi
T
T
Karhu
R
R
Kallioniemi
A
A
D001943:Breast Neoplasms / Q000235:genetics*; D045744:Cell Line, Tumor; D002886:Chromosomes, Human, Pair 17; D005260:Female; D005784:Gene Amplification; D018628:Gene Dosage; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D020133:Reverse Transcriptase Polymerase Chain Reaction